Sean S. Evans
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sean S. Evans has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Do‐Yeon Cho
Department of Otolaryngology Head & Neck Surgery University of Alabama at Birmingham Birmingham Alabama USA
3 shared publications Joshua Richman
Department of Surgery, University of Alabama, Birmingham, AL, USA
3 shared publications- Holly Cordray
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
2 shared publications A. Woolley
Pediatric Ear, Nose and Throat Associates of Alabama, Children's Hospital of Alabama, Birmingham, AL, USA
1 shared publicationAddison Clark
Department of Biological and Environmental Sciences, Georgia College and State University, USA
1 shared publication- Annie N. Farrell
Department of Otolaryngology‐Head and Neck Surgery, School of Medicine Emory University Atlanta Georgia USA
1 shared publication
Latest Publications
- 5 February 2023
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 169 (2) , 444-446
Atypical Head and Neck Phlegmons as an Early Indicator to MIS‐C in the Pediatric Population
- 5 February 2023
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 169 (2) , 444-446
Atypical Head and Neck Phlegmons as an Early Indicator to MIS‐C in the Pediatric Population
- 26 November 2022
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 164, 111404
Sirolimus-induced pulmonary hemorrhage of an infant with massive cervicofacial lymphatic malformation: A case report
- 26 November 2022
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 164, 111404
Sirolimus-induced pulmonary hemorrhage of an infant with massive cervicofacial lymphatic malformation: A case report
- 13 October 2022
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 163, 111333
Evaluating obesity as a risk factor for complications after pediatric adenotonsillectomy
- 13 October 2022
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 163, 111333
Evaluating obesity as a risk factor for complications after pediatric adenotonsillectomy
- 20 September 2022
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 168 (4) , 893-897
Virtually Assisted Personalized Tracheostomy Tube Design in Pediatric Complex Airway Anomalies
We sought to assess the feasibility of virtually assisted personalized tracheostomy tube (vapTT) implementation for patients with congenital airway anomalies (CAAs) and persistent tracheostomy tube (TT)–related respiratory failure at a tertiary pediatric hospital. Three patients (0‐18 years) with CAAs and recurrent TT‐related respiratory complications were managed with vapTT over 5 years. Patients underwent airway computed tomography acquisition with 3‐dimensional reconstruction and TT virtual modeling for shape customization. Models were transferred to Bivona for fabrication based on industry‐standard materials and processes. Clinical information and tracheoscopies assessing position, obstruction, and granulation were reviewed. Patients demonstrated resolution of visualized TT‐related obstruction, granulation, or ulceration and de‐escalation of respiratory support. Clinical events requiring urgent tracheoscopy decreased in all 3 patients. Sufficient relief of critical airway obstruction allowed progression of medical care and/or discharge. VapTTs are feasible for patients with CAA. This new frontier in personalized devices may serve uniquely challenging patient populations for whom standard treatments have failed.
- 20 September 2022
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 168 (4) , 893-897
Virtually Assisted Personalized Tracheostomy Tube Design in Pediatric Complex Airway Anomalies
We sought to assess the feasibility of virtually assisted personalized tracheostomy tube (vapTT) implementation for patients with congenital airway anomalies (CAAs) and persistent tracheostomy tube (TT)–related respiratory failure at a tertiary pediatric hospital. Three patients (0‐18 years) with CAAs and recurrent TT‐related respiratory complications were managed with vapTT over 5 years. Patients underwent airway computed tomography acquisition with 3‐dimensional reconstruction and TT virtual modeling for shape customization. Models were transferred to Bivona for fabrication based on industry‐standard materials and processes. Clinical information and tracheoscopies assessing position, obstruction, and granulation were reviewed. Patients demonstrated resolution of visualized TT‐related obstruction, granulation, or ulceration and de‐escalation of respiratory support. Clinical events requiring urgent tracheoscopy decreased in all 3 patients. Sufficient relief of critical airway obstruction allowed progression of medical care and/or discharge. VapTTs are feasible for patients with CAA. This new frontier in personalized devices may serve uniquely challenging patient populations for whom standard treatments have failed.
- 12 June 2022
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 159, 111209
Sustaining standardized opioid prescribing practices after pediatric tonsillectomy
- 12 June 2022
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 159, 111209
Sustaining standardized opioid prescribing practices after pediatric tonsillectomy
- 15 July 2020
- Published by Wiley in The Laryngoscope
- Vol. 131 (5) , 950-951
Persistent OSA After Adenotonsillectomy in CPAP‐Intolerant Children: What To Do Next?
- 15 July 2020
- Published by Wiley in The Laryngoscope
- Vol. 131 (5) , 950-951
Persistent OSA After Adenotonsillectomy in CPAP‐Intolerant Children: What To Do Next?
- 9 August 2019
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 129 (1) , 12-17
Validation of the Maxillary Sinus Roof as a Landmark for Navigating the Pediatric Skull Base
Objective: To define a new anatomic relationship in pediatric sinus surgery, assessing the maxillary roof as a constant safe landmark to avoid skull base injury in the pediatric population. Study Design: Retrospective analysis. Setting: Tertiary care children hospital. Subjects and Methods: A retrospective analysis was performed of all computed tomography scans of the sinuses and facial bones at the emergency department of a tertiary children’s hospital over the course of a year. Radiographic measurements included the lowest cribriform plate and planum sphenoidale (PS) heights, or posterior skull base when not yet pneumatized, as well as the highest maxillary roof height. The nasal floor was used for reference. Statistics were performed via Shapiro-Wilks test with a P-value of .05 indicating statistical significance. Results: Three hundred and seven unique scans were reviewed (38.9% female; n = 122; P = .58). Age stratification was based on previously described sinus growth patterns. In all patients, the maximum maxillary height was inferior to the lowest measured cribriform lamella and PS ( P < .001; CI, 98.5%-99%). Inter- and intrarater reliability and accuracy were verified through blinded review and re-review (ρ = .99 and .98 respectively, P ≤ .001). The validity of sole coronal measurements due to incomplete sagittal reformatting was also confirmed (ρ = 1.00, P ≤ .001). Conclusion: Despite variation in sinus growth and development in children, the current study demonstrated the validity of the maxillary sinus roof as a constant safe landmark in the pediatric population, offering a novel anatomic relationship for teaching safety in performing pediatric sinus surgery. Level of Evidence: 4
- 9 August 2019
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 129 (1) , 12-17
Validation of the Maxillary Sinus Roof as a Landmark for Navigating the Pediatric Skull Base
Objective: To define a new anatomic relationship in pediatric sinus surgery, assessing the maxillary roof as a constant safe landmark to avoid skull base injury in the pediatric population. Study Design: Retrospective analysis. Setting: Tertiary care children hospital. Subjects and Methods: A retrospective analysis was performed of all computed tomography scans of the sinuses and facial bones at the emergency department of a tertiary children’s hospital over the course of a year. Radiographic measurements included the lowest cribriform plate and planum sphenoidale (PS) heights, or posterior skull base when not yet pneumatized, as well as the highest maxillary roof height. The nasal floor was used for reference. Statistics were performed via Shapiro-Wilks test with a P-value of .05 indicating statistical significance. Results: Three hundred and seven unique scans were reviewed (38.9% female; n = 122; P = .58). Age stratification was based on previously described sinus growth patterns. In all patients, the maximum maxillary height was inferior to the lowest measured cribriform lamella and PS ( P < .001; CI, 98.5%-99%). Inter- and intrarater reliability and accuracy were verified through blinded review and re-review (ρ = .99 and .98 respectively, P ≤ .001). The validity of sole coronal measurements due to incomplete sagittal reformatting was also confirmed (ρ = 1.00, P ≤ .001). Conclusion: Despite variation in sinus growth and development in children, the current study demonstrated the validity of the maxillary sinus roof as a constant safe landmark in the pediatric population, offering a novel anatomic relationship for teaching safety in performing pediatric sinus surgery. Level of Evidence: 4
- 30 April 2019
- Published by Wiley in The Laryngoscope
- Vol. 130 (2) , 556-560
Increasing preoperative apnea severity improves upper airway stimulation response in OSA treatment
Objective: Examine the patient characteristics of those undergoing upper airway stimulation (UAS) for the treatment of continuous positive airway pressure (CPAP)‐refractive obstructive sleep apnea (OSA) at a tertiary care medical center to determine objective clinical predictors of success.Methods: Retrospective chart review of the first 25 consecutive patients between August 2015 and December 2016 treated with UAS at a tertiary care academic center. Demographic data, medical and sleep history, pre‐ and postoperative polysomnography data, and sleep endoscopy findings were collected. Statistical analysis was performed using two‐sided t test with bivariate and linear regression analysis.Results: In our cohort of 25 patients, mean age was 67.5 ± 7.6 years, and mean body mass index (BMI) was 28.2 ± 3.8 kg/m2 with 42% female. One patient was excluded from analysis for unmasking of complete central apnea with therapy. AHI decreased by a mean of 33.8 events/hour following treatment (95% confidence interval: 25.8 to 41.7, P < 0.001). Preintervention AHI was associated with therapy response, with each point of preintervention AHI leading to an average decrease of 1.03 points (P < 0.001). Eighty‐three percent of patients achieved a treatment AHI < 5, whereas 92% achieved an AHI < 10. Mean device use was 49.5 ± 10.4 hours per week. Ninety‐two percent of patients were discharged the day of surgery. No major adverse events occurred.Conclusion: UAS continues to gain popularity for the treatment of CPAP‐refractive OSA; therefore, identification of predictors of success is crucial. Our study, although small, suggests that more severe preintervention AHI does not preclude significant therapy response and may expand the inclusion criteria for UAS, meriting further investigation.Level of Evidence: 4 Laryngoscope, 130:556–560, 2020
- 30 April 2019
- Published by Wiley in The Laryngoscope
- Vol. 130 (2) , 556-560
Increasing preoperative apnea severity improves upper airway stimulation response in OSA treatment
Objective: Examine the patient characteristics of those undergoing upper airway stimulation (UAS) for the treatment of continuous positive airway pressure (CPAP)‐refractive obstructive sleep apnea (OSA) at a tertiary care medical center to determine objective clinical predictors of success.Methods: Retrospective chart review of the first 25 consecutive patients between August 2015 and December 2016 treated with UAS at a tertiary care academic center. Demographic data, medical and sleep history, pre‐ and postoperative polysomnography data, and sleep endoscopy findings were collected. Statistical analysis was performed using two‐sided t test with bivariate and linear regression analysis.Results: In our cohort of 25 patients, mean age was 67.5 ± 7.6 years, and mean body mass index (BMI) was 28.2 ± 3.8 kg/m2 with 42% female. One patient was excluded from analysis for unmasking of complete central apnea with therapy. AHI decreased by a mean of 33.8 events/hour following treatment (95% confidence interval: 25.8 to 41.7, P < 0.001). Preintervention AHI was associated with therapy response, with each point of preintervention AHI leading to an average decrease of 1.03 points (P < 0.001). Eighty‐three percent of patients achieved a treatment AHI < 5, whereas 92% achieved an AHI < 10. Mean device use was 49.5 ± 10.4 hours per week. Ninety‐two percent of patients were discharged the day of surgery. No major adverse events occurred.Conclusion: UAS continues to gain popularity for the treatment of CPAP‐refractive OSA; therefore, identification of predictors of success is crucial. Our study, although small, suggests that more severe preintervention AHI does not preclude significant therapy response and may expand the inclusion criteria for UAS, meriting further investigation.Level of Evidence: 4 Laryngoscope, 130:556–560, 2020
- 15 January 2019
- Published by Wiley in The Laryngoscope
- Vol. 129 (11) , E389-E394
Revisiting age‐related admission following tonsillectomy in the pediatric population
Objectives/Hypothesis: The objectives of this study were to examine patient outcomes using a 36‐month age cutoff as a strict admission criterion following tonsillectomy, and review the safety and determine the plausibility of same‐day discharge of children under 3 years old following tonsillectomy.Study Design: Retrospective chart review.Methods: A chart review of patients aged 24 to 42 months undergoing tonsillectomy over a 3‐year period was conducted. Patients were stratified into 2 and Wilcoxon tests for categorical and continuous variables.Results: Between July 2014 and July 2017, 427 patients aged 24 to 42 months underwent tonsillectomy at our institution. Thirty‐day emergency department visit, readmission, and greater‐than‐expected length of stay rates were 3.0% versus 3.7% (P = .75), 1.0 versus 1.8% (P = .61), and 4.7% versus 4.5% (P = 1.00) between the younger and older cohorts, respectively, with no difference in complication rates identified based on age.Conclusions: No significant difference in adverse outcomes was appreciated based on a cutoff of 36 months of age at a tertiary center over 3 years. There should continue to be ongoing studies addressing strict age‐related admission criteria.Level of Evidence: 4 Laryngoscope, 129:E389–E394, 2019
- 15 January 2019
- Published by Wiley in The Laryngoscope
- Vol. 129 (11) , E389-E394
Revisiting age‐related admission following tonsillectomy in the pediatric population
Objectives/Hypothesis: The objectives of this study were to examine patient outcomes using a 36‐month age cutoff as a strict admission criterion following tonsillectomy, and review the safety and determine the plausibility of same‐day discharge of children under 3 years old following tonsillectomy.Study Design: Retrospective chart review.Methods: A chart review of patients aged 24 to 42 months undergoing tonsillectomy over a 3‐year period was conducted. Patients were stratified into 2 and Wilcoxon tests for categorical and continuous variables.Results: Between July 2014 and July 2017, 427 patients aged 24 to 42 months underwent tonsillectomy at our institution. Thirty‐day emergency department visit, readmission, and greater‐than‐expected length of stay rates were 3.0% versus 3.7% (P = .75), 1.0 versus 1.8% (P = .61), and 4.7% versus 4.5% (P = 1.00) between the younger and older cohorts, respectively, with no difference in complication rates identified based on age.Conclusions: No significant difference in adverse outcomes was appreciated based on a cutoff of 36 months of age at a tertiary center over 3 years. There should continue to be ongoing studies addressing strict age‐related admission criteria.Level of Evidence: 4 Laryngoscope, 129:E389–E394, 2019